Combination treatment of orexin-A and NAB-paclitaxel in pancreas cancer: in vitro and in vivo studies

被引：0
|
作者：
Voisin, Thierry
Plaut, Dina
Dayot, Stephanie
Bergere, Maxime
Gratio, Valerie
Nicole, Pascal
Couvelard, Anne
Couvineau, Alain
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4581
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Combination carboplatin and nab-paclitaxel as a first-line treatment for advanced thymic carcinoma
    Manaka, Hiroya
    Igawa, Satoshi
    Yamamoto, Michiko
    Oguri, Akito
    Manabe, Hideaki
    Kasajima, Masashi
    Kusuhara, Seiichiro
    Hosotani, Shinji
    Nakahara, Yoshiro
    Sato, Takashi
    Fukui, Tomoya
    Hisashi, Mitsufuji
    Sasaki, Jiichiro
    Naoki, Katsuhiko
    INVESTIGATIONAL NEW DRUGS, 2023, 41 (01) : 115 - 121
  • [42] Nab-paclitaxel and trastuzumab combination: a promising approach for neoadjuvant treatment in HER2-positive breast cancer
    Ricciardi, Giuseppina Rosaria Rita
    Franchina, Tindara
    Russo, Alessandro
    Schifano, Silvia
    Ferraro, Giuseppa
    Adamo, Vincenzo
    ONCOTARGETS AND THERAPY, 2016, 9 : 4351 - 4355
  • [43] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Hakon Blomstrand
    Ursula Scheibling
    Charlotte Bratthäll
    Henrik Green
    Nils O. Elander
    BMC Cancer, 19
  • [44] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Kang, Connie
    Syed, Yahiya Y.
    DRUGS, 2020, 80 (06) : 601 - 607
  • [45] Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer
    Kawaida, Hiromichi
    Kono, Hiroshi
    Amemiya, Hidetake
    Saitou, Ryou
    Yamamoto, Atsushi
    Hosomura, Naohiro
    Watanabe, Mitsuaki
    Kimura, Ayako
    Furuya, Shinji
    Shimizu, Hiroki
    Akaike, Hidenori
    Kawaguchi, Yoshihiko
    Sudo, Makoto
    Itakura, Jun
    Hayakawa, Hiroshi
    Shindo, Hiroko
    Takahashi, Ei
    Takano, Shinichi
    Fukasawa, Mitsuharu
    Ichikawa, Shintaro
    Fujii, Hideki
    Ichikawa, Daisuke
    ANTICANCER RESEARCH, 2018, 38 (11) : 6537 - 6542
  • [46] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Scheibling, Ursula
    Bratthall, Charlotte
    Green, Henrik
    Elander, Nils O.
    BMC CANCER, 2019, 19 (1)
  • [47] Economic evaluation for the US of nab-paclitaxel plus gemcitabine versus FOLFIRINOX versus gemcitabine in the treatment of metastatic pancreas cancer
    Gharaibeh, Mahdi
    McBride, Ali
    Bootman, J. Lyle
    Patel, Hitendra
    Abraham, Ivo
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (04) : 345 - 352
  • [48] Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
    Connie Kang
    Yahiya Y. Syed
    Drugs, 2020, 80 : 601 - 607
  • [49] A meta-analysis of the incidence and risk of skin toxicity with nab-paclitaxel and paclitaxel in cancer treatment
    Li, Hong-Bo
    Wang, Wen-Hui
    Wang, Zhi-Yong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (06): : 4279 - 4290
  • [50] A phase I/II trial of combination nab-paclitaxel and nintedanib or nab-paclitaxel and placebo in relapsed NSCLC adenocarcinoma (N3)
    Tokaca, N.
    Espinasse, A.
    Petruckevitch, A.
    Ellis, S.
    Yousaf, N.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    LUNG CANCER, 2017, 103 : S77 - S78
12345